42 Results for "

IKK2

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "IKK2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
44
44 Publications Verification
Cat. No.: HY-10074
CAS No.: 507475-17-4
Purity:  98.60%
Target:  

IKK STAT Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.
loading...
    loading...
38
38 Cited Publications
Cat. No.: HY-10519
CAS No.: 445430-58-0
Purity:  99.86%
Target:  

IKK

Research Areas:  

Cancer

BMS-345541 is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
loading...
    loading...
38
38 Cited Publications
Cat. No.: HY-10518
CAS No.: 547757-23-3
Purity:  99.90%
Target:  

IKK

Research Areas:  

Cancer

BMS-345541 hydrochloride is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541 binds at an allosteric site of IKK.
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-13687
CAS No.: 873225-46-8
Purity:  99.88%
IKK 16 is an orally active IKK inhibitor. IKK 16 shows IC50s of 40 nM, 70 nM, 200 nM, and 50 nM for IKK2, IKK complex, IKK1, and LRRK 2, respectively. IKK 16 is also a pan-PKD inhibitor, inhibiting PKD1, PKD2, and PKD3 with IC50s of 153.9, 115, and 99.7 nM, respectively. IKK 16 is also an ABCB1 inhibitor, interfering with the binding of ABCB1 to its substrates. IKK 16 protects against LPS (HY-D1056)-induced multiple organ dysfunction by reducing the acute inflammatory response induced by endotoxin exposure. IKK 16 can restore renal function and alleviate fibrosis in acute kidney injury. IKK 16 attenuates cardiac dysfunction associated with polymicrobial sepsis in mice with type 2 diabetes mellitus (T2DM) by inhibiting the NF-κB pathway [2] .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-13687A
CAS No.: 1186195-62-9
Purity:  99.95%
IKK 16 hydrochloride is an orally active IKK inhibitor. IKK 16 hydrochloride shows IC50s of 40 nM, 70 nM, 200 nM, and 50 nM for IKK2, IKK complex, IKK1, and LRRK 2, respectively. IKK 16 hydrochloride is also a pan-PKD inhibitor, inhibiting PKD1, PKD2, and PKD3 with IC50s of 153.9, 115, and 99.7 nM, respectively. IKK 16 hydrochloride is also an ABCB1 inhibitor, interfering with the binding of ABCB1 to its substrates. IKK 16 hydrochloride protects against LPS (HY-D1056)-induced multiple organ dysfunction by reducing the acute inflammatory response induced by endotoxin exposure. IKK 16 hydrochloride can restore renal function and alleviate fibrosis in acute kidney injury. IKK 16 hydrochloride attenuates cardiac dysfunction associated with polymicrobial sepsis in mice with type 2 diabetes mellitus (T2DM) by inhibiting the NF-κB pathway [2] .
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-10172
CAS No.: 978-62-1
Purity:  99.26%
Synonyms: IKK2 Inhibitor V
Target:  

IKK

Research Areas:  

Cancer

IMD-0354 (IKK2 Inhibitor V) is a selective IKKβ inhibitor which inhibits NF-κB activity . IMD0354 inhibits TNF-α induced NF-κB transcription activity with an IC50 of 1.2 uM [2].
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-13060
CAS No.: 406209-26-5
Purity:  99.94%
Synonyms: IKK-2 Inhibitor VIII
Target:  

IKK

Research Areas:  

Inflammation/Immunology

ACHP Hydrochloride (IKK-2 Inhibitor VIII) is a highly potent and selective IKK-β inhibitor with an IC50 of 8.5 nM.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-13802
CAS No.: 354812-17-2
Purity:  99.89%
Synonyms: GK 01140
Target:  

IKK

Research Areas:  

Cancer

SC-514 is a selective IKK-2 inhibitor (IC50=11.2 μM), which does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-131249
CAS No.: 724711-21-1
Purity:  99.15%
Target:  

MAPKAPK2 (MK2)

Research Areas:  

Inflammation/Immunology

MK2-IN-3 is a potent and selective inhibitor of MAPKAP-K2 (MK-2), with an IC50 of 8.5 nM. MK2-IN-3 shows selectivity for MK-2 over MK-3, MK-5, ERK2, MNK1, p38a (IC50s=0.21, 0.081, 3.44, 5.7, and >100 μM, respectively) and MSK1, MSK2, CDK2, JNK2, IKK2 (IC50s>200 μM). MK2-IN-3 can reduce TNFα production in both U937 cells and in vivo .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-B0788A
CAS No.: 946518-60-1
Target:  

IKK Apoptosis

Research Areas:  

Cancer

LY2409881 trihydrochloride is a selective IκB kinase β (IKK2) inhibitor with an IC50 of 30 nM.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112457
CAS No.: 1186648-22-5
Purity:  98.03%
Target:  

MAPKAPK2 (MK2)

Research Areas:  

Inflammation/Immunology

MK2-IN-3 hydrate (compound 16) is an orally active, selective, and ATP-competitive MAPKAP-K2 (MK-2) inhibitor with an IC50 of 8.5 nM.MK2-IN-3 hydrate is exceptional selectivity against MK-3 (IC50=0.21 μM), MK-5 (IC50=0.081 μM), ERK2 (IC50=3.44 μM), MNK1(IC50=5.7 μM) as well as CDK2, JNK2, IKK2, MSK1, and MSK2 .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19362
CAS No.: 1609281-86-8
Target:  

IKK

Research Areas:  

Inflammation/Immunology

AZD3264 is a selective IkB-kinase IKK2 inhibitor.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14682
CAS No.: 862812-98-4
Purity:  99.25%
Target:  

IKK

Research Areas:  

Inflammation/Immunology

GSK319347A is a dual inhibitor of TBK1 and IKKε with IC50s of 93 nM and 469 nM, respectively. GSK319347A also inhibits IKK2 with an IC50 of 790 nM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14180
CAS No.: 503555-55-3
Purity:  99.40%
PHA-408 is a highly selective, orally active and ATP-competitive IKK-2 inhibitor with an IC50 of 40 nM. PHA-408 blocks NF-κB signaling by suppressing IκBα phosphorylation and degradation, p65 phosphorylation, and pro-inflammatory cytokine production, and prevents TNF-α-induced premature senescence in HUVECs. PHA-408 alleviates LPS-and cigarette smoke-triggered pulmonary inflammation, reduces LPS-stimulated serum TNF-α release, and ameliorates joint damage in SCW-induced arthritis in rats. PHA-408 is applicable for the research of rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), and Duchenne muscular dystrophy [2] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P701786
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IKBKβ; Inhibitor of nuclear factor kappa-B kinase subunit beta; I-kappa-B-kinase beta; IKK-B; IKK-beta; IkBKB; I-kappa-B kinase 2; IKK2; Nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB; Serine/threonine protein kinase IKBKB
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-112456
CAS No.: 354811-10-2
Purity:  99.89%
Target:  

IKK

Research Areas:  

Inflammation/Immunology

IKK2-IN-4 (compound 4) is a potent IKK-2 inhibitor, with an IC50 of 25 nM. IKK2-IN-4 can inhibit the LPS-induced production of TNFα in PBMCs .
loading...
    loading...
Cat. No.: HY-111135
CAS No.: 916985-21-2
Purity:  ≥98.0%
Target:  

IKK

Research Areas:  

Inflammation/Immunology Cancer

IKK2-IN-3 is an IKK2 inhibitor with an IC50 value of 0.075 μM. IKK2-IN-3 can be used for the research of cancer, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
Cat. No.: HY-B0788
CAS No.: 946518-61-2
Target:  

IKK

Research Areas:  

Cancer

LY2409881 is a selective IκB kinase β (IKK2) inhibitor with an IC50 of 30 nM.
loading...
    loading...
Cat. No.: HY-107591A
Purity:  ≥98.0%
Target:  

IKK

Research Areas:  

Inflammation/Immunology

(Rac)-PF-184 hydrate is a potent inhibitory factor-κB kinase 2 (IKK-2) inhibitor with an IC50 of 37 nM. (Rac)-PF-184 hydrate has anti-inflammatory effects .
loading...
    loading...
Cat. No.: HY-10172R
CAS No.: 978-62-1
Synonyms: IKK2 Inhibitor V (Standard)
Target:  

Reference Standards IKK

Research Areas:  

Cancer

IMD-0354 (Standard) is the analytical standard of IMD-0354. This product is intended for research and analytical applications. IMD-0354 (IKK2 Inhibitor V) is a selective IKKβ inhibitor which inhibits NF-κB activity . IMD0354 inhibits TNF-α induced NF-κB transcription activity with an IC50 of 1.2 uM [2].
loading...
    loading...